Adenovirus-mediated bone morphogenetic protein-2 promotes osteogenic differentiation in human mesenchymal stem cells in vitro

Cao,Hong; Sun,Zhi‑Bo; Zhang,Lei; Qian,Wei; Li,Chun‑Yang; Guo,Xiao‑Peng; Zhang,Ying

doi:10.3892/etm.2017.4482

Adenovirus-mediated bone morphogenetic protein-2 promotes osteogenic differentiation in human mesenchymal stem cells in vitro

Authors:
- Hong Cao
- Zhi‑Bo Sun
- Lei Zhang
- Wei Qian
- Chun‑Yang Li
- Xiao‑Peng Guo
- Ying Zhang
View Affiliations

Affiliations: Department of Orthopedic Surgery, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Reproductive Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China, Department of Orthopedic Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China
Published online on: May 22, 2017 https://doi.org/10.3892/etm.2017.4482
Pages: 377-382

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Delayed and failed bone union following fracture is a common clinical complication that requires treatment in orthopedics. Cell‑based therapies and tissue‑engineering approaches are potential therapeutic strategies for bone repair and fracture healing. However, the effect of adenovirus expressing bone morphogenetic protein‑2 (Ad‑BMP‑2) on the osteogenic ability of human mesenchymal stem cells (hMSCs) has remained to be fully elucidated. Therefore, in the present study, hMSCs were transduced using Ad‑BMP‑2 to assess the effects of its application and to determine whether Ad‑BMP‑2 promotes the osteogenic differentiation of hMSCs. The purity of the hMSC cultures was assessed using flow cytometric analysis. In order to assess the osteogenic activity, alkaline phosphatase activity (ALP) was measured and to estimate the osteoblastic mineralization and calcification, von Kossa staining for phosphates was performed. Cells positive for Src homology 2 domain were determined to be hMSCs and the presence of CD34 was used to distinguish hematopoietic lineages. Following treatment, the Ad‑BMP‑2 and control group had significantly increased ALP levels (P<0.05). Compared to the blank group and the group transfected with adenoviral vector containing LacZ, the phosphate deposition in the Ad‑BMP‑2 group and the positive control group treated with dexamethasone was markedly increased. The results of the present study suggested that Ad‑BMP‑2 promotes osteogenic differentiation in hMSCs and may have a potential application in treating delayed union and nonunion following bone fracture.

View Figures

View References

1	Dahabreh Z, Dimitriou R and Giannoudis PV: Health economics: A cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury. 38:371–377. 2007. View Article : Google Scholar : PubMed/NCBI
2	Marsh D: Concepts of fracture union, delayed union, and nonunion. Clin Orthop Relat Res. Suppl 355:22–30. 1998. View Article : Google Scholar
3	Obermeyer TS, Yonick D, Lauing K, Stock SR, Nauer R, Strotman P, Shankar R, Gamelli R, Stover M and Callaci JJ: Mesenchymal stem cells facilitate fracture repair in an alcohol-induced impaired healing model. J Orthop Trauma. 26:712–718. 2012. View Article : Google Scholar : PubMed/NCBI
4	Qi Y, Zhao T, Yan W, Xu K, Shi Z and Wang J: Mesenchymal stem cell sheet transplantation combined with locally released simvastatin enhances bone formation in a rat tibia osteotomy model. Cytotherapy. 15:44–56. 2013. View Article : Google Scholar : PubMed/NCBI
5	Aldahmash A, Zaher W, Al-Nbaheen M and Kassem M: Human stromal (mesenchymal) stem cells: Basic biology and current clinical use for tissue regeneration. Ann Saudi Med. 32:68–77. 2012. View Article : Google Scholar : PubMed/NCBI
6	Zhang ZY, Teoh SH, Hui JH, Fisk NM, Choolani M and Chan JK: The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering application. Biomaterials. 33:2656–2672. 2012. View Article : Google Scholar : PubMed/NCBI
7	D'Ippolito G, Schiller PC, Ricordi C, Roos BA and Howard GA: Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 14:1115–1122. 1999. View Article : Google Scholar : PubMed/NCBI
8	Rodríguez JP, Ríos S, Fernández M and Santibañez JF: Differential activation of ERK1,2 MAP kinase signaling pathway in mesenchymal stem cell from control and osteoporotic postmenopausal women. J Cell Biochem. 92:745–754. 2004. View Article : Google Scholar : PubMed/NCBI
9	Rodríguez JP, Montecinos L, Ríos S, Reyes P and Martínez J: Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem. 79:557–565. 2000. View Article : Google Scholar : PubMed/NCBI
10	Finkemeier CG: Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 84-A:454–464. 2002. View Article : Google Scholar : PubMed/NCBI
11	Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, et al: Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am. 85-A:1544–1552. 2003. View Article : Google Scholar : PubMed/NCBI
12	Dai KR, Xu XL, Tang TT, Zhu ZA, Yu CF, Lou JR and Zhang XL: Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int. 77:55–61. 2005. View Article : Google Scholar : PubMed/NCBI
13	Sun D, Junger WG, Yuan C, Zhang W, Bao Y, Qin D, Wang C, Tan L, Qi B, Zhu D, et al: Shockwaves induce osteogenic differentiation of human mesenchymal stem cells through ATP release and activation of P2X7 receptors. Stem Cells. 31:1170–1180. 2013. View Article : Google Scholar : PubMed/NCBI
14	Roseti L, Serra M and Bassi A: Standard operating procedure for the good manufacturing practice-compliant production of human bone marrow mesenchymal stem cells. Methods Mol Biol. 1283:171–186. 2015. View Article : Google Scholar : PubMed/NCBI
15	Foster LJ, Zeemann PA, Li C, Mann M, Jensen ON and Kassem M: Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation. Stem Cells. 23:1367–1377. 2005. View Article : Google Scholar : PubMed/NCBI
16	Hammoud M, Vlaski M, Duchez P, Chevaleyre J, Lafarge X, Boiron JM, Praloran V, De La Grange P Brunet and Ivanovic Z: Combination of low O(2) concentration and mesenchymal stromal cells during culture of cord blood CD34(+) cells improves the maintenance and proliferative capacity of hematopoietic stem cells. J Cell Physiol. 227:2750–2758. 2012. View Article : Google Scholar : PubMed/NCBI
17	Li WC, Wang DP, Li LJ, Zhu WM and Zeng YJ: Adenovirus- mediated bone morphogenetic protein-2 gene transfection of bone marrow mesenchymal stem cells combined with nano-hydroxyapatite to construct bone graft material in vitro. Artif Cells Nanomed Biotechnol. 41:103–108. 2013. View Article : Google Scholar : PubMed/NCBI
18	Mukaiyama K, Kamimura M, Uchiyama S, Ikegami S, Nakamura Y and Kato H: Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover. Aging Clin Exp Res. 27:413–418. 2013. View Article : Google Scholar
19	Williams DC and Frolik CA: Physiological and pharmacological regulation of biological calcification. Int Rev Cytol. 126:195–292. 1991. View Article : Google Scholar : PubMed/NCBI
20	Zura R, Braid-Forbes MJ, Jeray K, Mehta S, Einhorn TA, Watson JT, Rocca GJ Della, Forbes K and Steen RG: Bone fracture nonunion rate decreases with increasing age: A prospective inception cohort study. Bone. 95:26–32. 2017. View Article : Google Scholar : PubMed/NCBI
21	Liebergall M, Schroeder J, Mosheiff R, Gazit Z, Yoram Z, Rasooly L, Daskal A, Khoury A, Weil Y and Beyth S: Stem cell-based therapy for prevention of delayed fracture union: A randomized and prospective preliminary study. Mol Ther. 21:1631–1638. 2013. View Article : Google Scholar : PubMed/NCBI
22	Mathieu M, Rigutto S, Ingels A, Spruyt D, Stricwant N, Kharroubi I, Albarani V, Jayankura M, Rasschaert J, Bastianelli E and Gangji V: Decreased pool of mesenchymal stem cells is associated with altered chemokines serum levels in atrophic nonunion fractures. Bone. 53:391–398. 2013. View Article : Google Scholar : PubMed/NCBI
23	Jiang X, Zou S, Ye B, Zhu S, Liu Y and Hu J: bFGF-Modified BMMSCs enhance bone regeneration following distraction osteogenesis in rabbits. Bone. 46:1156–1161. 2010. View Article : Google Scholar : PubMed/NCBI
24	Cuomo AV, Virk M, Petrigliano F, Morgan EF and Lieberman JR: Mesenchymal stem cell concentration and bone repair: Potential pitfalls from bench to bedside. J Bone Joint Surg Am. 91:1073–1083. 2009. View Article : Google Scholar : PubMed/NCBI
25	Chamberlain G, Fox J, Ashton B and Middleton J: Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar : PubMed/NCBI
26	Quent VM, Theodoropoulos C, Hutmacher DW and Reichert JC: Differential osteogenicity of multiple donor-derived human mesenchymal stem cells and osteoblasts in monolayer, scaffold-based 3D culture and in vivo. Biomed Tech (Berl). 61:253–166. 2016. View Article : Google Scholar : PubMed/NCBI
27	Lee TH, Kim WT, Ryu CJ and Jang YJ: Optimization of treatment with recombinant FGF-2 for proliferation and differentiation of human dental stem cells, mesenchymal stem cells, and osteoblasts. Biochem Cell Biol. 93:298–305. 2015. View Article : Google Scholar : PubMed/NCBI
28	Meijer GJ, De Bruijn JD, Koole R and van Blitterswijk CA: Cell-based bone tissue engineering. PLoS Med. 4:e92007. View Article : Google Scholar : PubMed/NCBI
29	Hong D, Chen HX, Ge R and Li JC: Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering. Anat Rec (Hoboken). 293:531–537. 2010. View Article : Google Scholar : PubMed/NCBI
30	Rastall DP and Amalfitano A: Recent advances in gene therapy for lysosomal storage disorders. Appl Clin Genet. 8:157–169. 2015.PubMed/NCBI
31	Liddle OL, Samuel MI, Sudhanva M, Ellis J and Taylor C: Adenovirus urethritis and concurrent conjunctivitis: A case series and review of the literature. Sex Transm Infect. 91:87–90. 2015. View Article : Google Scholar : PubMed/NCBI
32	Balmayor ER and van Griensven M: Gene therapy for bone engineering. Front Bioeng Biotechnol. 3:92015. View Article : Google Scholar : PubMed/NCBI
33	Pruessner HT: Detecting celiac disease in your patients. Am Fam Physician. 57:1023–1034, 1039-1041. 1998.PubMed/NCBI